Company: HFFG
Filing Date: 2025-04-07
Form Type: S-3/A
Source: 0001628280-25-016967
Chunk: 3

Company: HF Foods Group Inc.
Filing Date: 2025-04-07
Form: S-3/A
Chunk 3
---
 Food, Inc., Connie Wang, Jenny Wang and Great Wall Seafood VA, L.L.C. and the Company; and (vi) upon the settlement of certain equity awards granted pursuant to the Company’s equity incentive plans.

We are registering the shares of our common stock on behalf of the selling stockholders, to be offered and sold by them from time to time. We are not selling any securities under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders.

This prospectus provides a general description of the common stock the selling stockholders may offer. The selling stockholders may sell the shares of our common stock described in this prospectus in a number of different ways and at varying prices. See the section titled “ Plan of Distribution ” on page 16 of this prospectus for more information about how the selling stockholders may sell the shares of common stock being registered pursuant to this prospectus.

We are paying certain expenses incurred in registering the shares of common stock, including certain legal, accounting fees and registration fees. The selling stockholders will bear all underwriting discounts, selling commissions and similar fees and arrangements and stock transfer taxes allocable to their respective sales of the shares of our common stock and certain additional legal and advisor fees.

Our common stock is listed on the NASDAQ Capital Market (the “NASDAQ”) under the symbol “HFFG.” The applicable prospectus supplement will contain information, where applicable, as to any other listing, if any, on the NASDAQ or any securities market or other exchange of the securities covered by the applicable prospectus supplement. On April 4, 2025, the last reported sale price of our common stock on NASDAQ was $3.98 per share.

Investing in our securities involves a high degree of risk. See “

#### Risk Factors

#### ” beginning on page

#### 6
of this prospectus and contained in the applicable prospectus supplement and any related free writing prospectus, and under similar headings in the other documents that are incorporated by reference into this prospectus.

We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read the entire prospectus and any amendments or supplements carefully before you make your investment decision.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is